Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters

Database
Language
Journal subject
Affiliation country
Publication year range
1.
Biomed Res Int ; 2022: 4496949, 2022.
Article in English | MEDLINE | ID: mdl-36262969

ABSTRACT

Background: Platelet-rich plasma (PRP) therapy is a new kind of biological therapy to retune the plasma concentrator into the patient's body for the treatment of osteoarthritis diseases. The present research aimsed to confirm the treatment effects of PRP against osteoarthritis injury and elucidate its potential mechanism via constructing a kind of cellular injury model of human synovial fibroblast cells (HSF cells) induced by synovial fluid from osteoarthritis patients. Materials and Methods: HSF cells wereas firstly treated with the different doses of synovial fluid from osteoarthritis patients, and evaluated for the cellular injury via cell morphology and MTT assay. And then, the protective effect of PRP against cellular injury were examined by cell morphology and MTT assay. Following, flow cytometry and western blot assay were employed to evaluate the effect of PRP on mitochondrial apoptosis. Finally, the effect of PRP on NF-κB pathway-associated inflammation wasere examined by Elisa ELISA assay and western blot. Results: The dilution ratio 1 : 5 of synovial fluid displayed an excellent injury effect against HSF cells and selected as the model condition. The data from cellular image and MTT assay showed that PRP with the doses 1 : 5 and 1 : 10 could alleviate the cellular mounts decrease in the damaged HSF cells. Flow cytometry, western blot, and Elisa ELISA assay displayed that PRP could relieve the cellular mitochondrial apoptosis and NF-κB pathway-associated inflammation in the damaged HSF cells. Conclusion: PRP might relieve HSF cells injury induced by synovial fluid from osteoarthritis patients through alleviating the mitochondrial apoptosis and NF-κB pathway-associated inflammation.


Subject(s)
Osteoarthritis , Platelet-Rich Plasma , Humans , NF-kappa B/metabolism , Synovial Fluid/metabolism , Apoptosis , Fibroblasts/metabolism , Platelet-Rich Plasma/metabolism , Osteoarthritis/therapy , Osteoarthritis/metabolism , Inflammation/metabolism , Cells, Cultured
2.
Int J Med Sci ; 8(7): 558-63, 2011.
Article in English | MEDLINE | ID: mdl-21960748

ABSTRACT

Epithelioid hemangioendothelioma (EH) is an uncommon low-grade malignant soft-tissue tumor; no case has been previously reported where multicentric epithelioid hemangioendothelioma occurred in the same lower extremity at different sites. We report a case involving the common peroneal nerve and subsequently the long bone and the short bones of the same lower extremity, and also review the literature. After establishing case of several lesions, we reviewed the histopathology properly and followed up the patient for a long time with serial whole body assessment to pick up any subsequent lesions.


Subject(s)
Bone Neoplasms/diagnosis , Hemangioendothelioma, Epithelioid/diagnosis , Bone Neoplasms/diagnostic imaging , Bone Neoplasms/pathology , Bones of Lower Extremity/diagnostic imaging , Bones of Lower Extremity/pathology , Female , Hemangioendothelioma, Epithelioid/diagnostic imaging , Hemangioendothelioma, Epithelioid/pathology , Humans , Lower Extremity/diagnostic imaging , Lower Extremity/pathology , Middle Aged , Peroneal Nerve/pathology , Radiography
SELECTION OF CITATIONS
SEARCH DETAIL